Inspire Medical Systems Beheer
Beheer criteriumcontroles 4/4
Momenteel beschikken wij niet over voldoende informatie over de CEO.
Belangrijke informatie
Tim Herbert
Algemeen directeur
US$7.5m
Totale compensatie
| Percentage CEO-salaris | 9.2% |
| Dienstverband CEO | 17yrs |
| Eigendom CEO | 1.0% |
| Management gemiddelde ambtstermijn | 4.3yrs |
| Gemiddelde ambtstermijn bestuur | 5.3yrs |
Recente managementupdates
Recent updates
Inspire Medical Systems, Inc. Just Recorded A 894% EPS Beat: Here's What Analysts Are Forecasting Next
Nov 07
A Look At The Intrinsic Value Of Inspire Medical Systems, Inc. (NYSE:INSP)
Oct 31Is Now The Time To Look At Buying Inspire Medical Systems, Inc. (NYSE:INSP)?
Oct 03After Leaping 39% Inspire Medical Systems, Inc. (NYSE:INSP) Shares Are Not Flying Under The Radar
Aug 08Is Inspire Medical Systems, Inc. (NYSE:INSP) Trading At A 39% Discount?
Jul 17At US$162, Is It Time To Put Inspire Medical Systems, Inc. (NYSE:INSP) On Your Watch List?
Jun 22Inspire Medical Systems, Inc.'s (NYSE:INSP) Stock Retreats 28% But Revenues Haven't Escaped The Attention Of Investors
May 09Inspire Medical Systems: A Potential Example Of Market Mispricing
Apr 05Inspire Medical Systems, Inc. (NYSE:INSP) Shares Could Be 23% Below Their Intrinsic Value Estimate
Mar 27Is There Now An Opportunity In Inspire Medical Systems, Inc. (NYSE:INSP)?
Mar 06Inspire Medical: A Good Night Sleep
Feb 08Inspire Medical Systems, Inc.'s (NYSE:INSP) 35% Jump Shows Its Popularity With Investors
Dec 26Inspire Medical Systems: Time To Wake Up
Nov 17An Intrinsic Calculation For Inspire Medical Systems, Inc. (NYSE:INSP) Suggests It's 38% Undervalued
Nov 13Inspire Medical Systems: Stock In A Deep Sleep Despite Stellar Sales Growth
Oct 25When Should You Buy Inspire Medical Systems, Inc. (NYSE:INSP)?
Sep 05Inspire Medical Systems: Excellent Execution And Reset Valuation
Aug 17Does This Valuation Of Inspire Medical Systems, Inc. (NYSE:INSP) Imply Investors Are Overpaying?
Aug 10Inspire Medical Systems: Revolutionizing Obstructive Sleep Apnea Treatment
Jul 19Inspire Medical Systems, Inc. (NYSE:INSP) Not Lagging Industry On Growth Or Pricing
Jul 16Inspire Medical Systems: Valuation, Sentiment, Fundamental Factors Call For Re-Rating
Jun 15Why Inspire Medical Systems, Inc. (NYSE:INSP) Could Be Worth Watching
May 06Inspire Medical stock rises after guiding revenue above estimates
Jan 09Analyse CEO-vergoeding
| Datum | Totale vergoeding | Salaris | Bedrijfswinsten |
|---|---|---|---|
| Sep 30 2024 | n/a | n/a | US$33m |
| Jun 30 2024 | n/a | n/a | US$6m |
| Mar 31 2024 | n/a | n/a | -US$16m |
| Dec 31 2023 | US$7m | US$690k | -US$21m |
| Sep 30 2023 | n/a | n/a | -US$33m |
| Jun 30 2023 | n/a | n/a | -US$41m |
| Mar 31 2023 | n/a | n/a | -US$44m |
| Dec 31 2022 | US$6m | US$645k | -US$45m |
| Sep 30 2022 | n/a | n/a | -US$50m |
| Jun 30 2022 | n/a | n/a | -US$44m |
| Mar 31 2022 | n/a | n/a | -US$43m |
| Dec 31 2021 | US$1m | US$620k | -US$42m |
| Sep 30 2021 | n/a | n/a | -US$47m |
| Jun 30 2021 | n/a | n/a | -US$47m |
| Mar 31 2021 | n/a | n/a | -US$57m |
| Dec 31 2020 | US$5m | US$506k | -US$57m |
| Sep 30 2020 | n/a | n/a | -US$59m |
| Jun 30 2020 | n/a | n/a | -US$57m |
| Mar 31 2020 | n/a | n/a | -US$41m |
| Dec 31 2019 | US$3m | US$440k | -US$33m |
| Sep 30 2019 | n/a | n/a | -US$29m |
| Jun 30 2019 | n/a | n/a | -US$25m |
| Mar 31 2019 | n/a | n/a | -US$24m |
| Dec 31 2018 | US$3m | US$418k | -US$22m |
| Sep 30 2018 | n/a | n/a | -US$21m |
| Jun 30 2018 | n/a | n/a | -US$21m |
| Mar 31 2018 | n/a | n/a | -US$20m |
| Dec 31 2017 | US$600k | US$380k | -US$18m |
Compensatie versus markt: De totale vergoeding ($USD 7.49M ) Tim } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 7.91M ).
Compensatie versus inkomsten: De vergoeding van Tim is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.
CEO
Tim Herbert (61 yo)
17yrs
Tenure
US$7,490,775
Compensatie
Mr. Timothy P. Herbert, also known as Tim, has been Chief Executive Officer, President and Director of Inspire Medical Systems, Inc. since November 2007 and has been its Chairman since May 2, 2024. He is t...
Leiderschapsteam
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 17yrs | US$7.49m | 0.99% $ 51.0m | |
| Chief Financial Officer | 10.5yrs | US$2.30m | 0.10% $ 5.3m | |
| Chief Commercial Officer | 5.8yrs | US$2.26m | 0.0023% $ 120.1k | |
| Chief Medical Officer | 1.3yrs | US$211.35k | 0.0031% $ 161.5k | |
| Chief Strategy Officer | 1.3yrs | US$2.10m | 0% $ 0 | |
| Chief Technology Officer | 2.5yrs | US$2.10m | 0.029% $ 1.5m | |
| Vice President of Investor Relations | no data | geen gegevens | geen gegevens | |
| Senior VP | 3.8yrs | US$2.69m | 0.0044% $ 225.6k | |
| Chief People Officer | less than a year | geen gegevens | geen gegevens | |
| Senior Vice President of U.S. Sales | 4.8yrs | geen gegevens | geen gegevens | |
| Executive VP & MD of Europe | 4.8yrs | geen gegevens | geen gegevens | |
| Director of Financial Reporting | no data | geen gegevens | geen gegevens |
4.3yrs
Gemiddelde duur
56yo
Gemiddelde leeftijd
Ervaren management: Het managementteam van INSP wordt beschouwd als ervaren (gemiddelde ambtstermijn 4.3 jaar).
Bestuursleden
| Naam | Positie | Tenure | Compensatie | Eigendom |
|---|---|---|---|---|
| Founder | 17yrs | US$7.49m | 0.99% $ 51.0m | |
| Independent Director | 16.8yrs | US$235.88k | 0.068% $ 3.5m | |
| Independent Director | 16.3yrs | US$238.38k | 0.069% $ 3.6m | |
| Independent Director | 7.8yrs | US$248.38k | 0.085% $ 4.4m | |
| Independent Director | 4.1yrs | US$243.38k | 0.0060% $ 307.9k | |
| Lead Independent Director | 5.3yrs | US$243.38k | 0.012% $ 616.9k | |
| Independent Director | 4.3yrs | US$238.38k | 0.0050% $ 258.8k | |
| Independent Director | less than a year | US$271.56k | 0% $ 0 | |
| Independent Director | 2.3yrs | US$235.88k | 0.0022% $ 115.4k |
5.3yrs
Gemiddelde duur
65yo
Gemiddelde leeftijd
Ervaren bestuur: De raad van bestuur van INSP wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.3 jaar).